JW Shinyak, a Kosdaq-listed biotech company, said Wednesday that it has started selling Ducray Neoptide Expert, Pierre Fabre’s hair loss relief cosmetic.Ducray Neoptide Expert is a specialized cosmetic for hair loss relief developed through clinical trials and is available at medical institutes for
Boehringer Ingelheim Korea said it has appointed Ana-Maria Boie as the new general manager (GM) and head of human pharma, effective from Jan. 15.According to the company, Ana-Maria Boie, the newly appointed GM, has worked in the pharmaceutical industry for 24 years and has amassed expertise in manag
Celltrion said Wednesday that it has signed a business agreement with WuXi XDC, a Chinese company specializing in antibody-drug conjugates (ADCs), to strengthen ADC drug development and to begin developing drugs for contract development and manufacturing organizations (CDMOs).WuXi XDC, a joint compa
Dong-A ST said it has partnered with the Korea Institute of Science and Technology (KIST) to develop a novel treatment for inflammatory bowel disease (IBD).Under the accord, Dong-A ST will acquire the patent rights for the oral nucleic acid therapy delivery technology developed by KIST's Biomedical
Hyundai Pharmaceutical said Tuesday that it has launched Complex Minoxyl Solution 240ml (minoxidil), a hair loss treatment containing vitamins and other scalp care ingredients.Complex Minoxyl Solution is a product that adds two vitamin ingredients, vitamin B6 (pyridoxine hydrochloride) and vitamin E
Ildong Pharmaceutical improved its profitability in the company’s performance results for 2023.Ildong Pharm disclosed its preliminary performance results for 2023 through a public announcement on Monday. The bottom lines showed that the company showed positive changes in operating income and net inc
AriBio, primarily known for its work to develop an oral Alzheimer's disease treatment candidate, has been penalized for the sale of cosmetics containing ingredients that are not permitted for use.The Ministry of Food and Drug Safety issued the penalty last Thursday, mandating a three-month suspensio
AbClon said Monday that AC101 (HLX in Chinese code name), licensed to Shanghai Henlius Biotech, has demonstrated potential as a first-line treatment for patients with HER2-positive gastric cancer in a phase 2 clinical trial.Henlius released interim results from the ongoing phase 2 clinical trial of
Merck Korea said it launched its Fertility Benefit Program for its employees and their spouses, effective from Jan. 1 this year.Merck Korea has about 1,750 employees, according to its website. The program, part of Merck's broader initiative "Fertility Counts," is designed to support the reproductive
Hanmi Pharm said that its combination antihypertensive drug, Amosartan Tab, has recorded cumulative sales of 1.05 trillion won ($786.2 million) as of December last year. The record was achieved more than 14 years after its launch, with sales averaging 75 billion won per year.Amosartan is a drug that
NeoImmuneTech, a Kosdaq-listed T-cell-based immunotherapy developer, said Monday that its pancreatic cancer drug, NT-I7 (efineptakin alfa), has received an orphan drug designation (ODD) from the U.S. FDA.The FDA's ODD system is designed to facilitate the development and approval of drugs to treat ra
Hanmi Pharm said Friday that the cumulative sales of Mok-N Spray, an over-the-counter drug for treating sore throat that was first launched in 2015, exceeded 3.91 million units.Mok-N sold more than 210,000 units in 2015, the first year of its launch, and it began to grow rapidly from the beginning o
GC Biopharma said that the intracerebroventricular (ICV) enzyme replacement therapy (ERT) drug for Sanfilippo Syndrome Type A, jointly developed with Korean biotech venture Novel Pharma, has been designated as an orphan drug by the European Medicines Agency (EMA).The recognition follows the drug's p
JW Pharmaceutical said Thursday that the results of a study demonstrating various physical activity data and safety in patients taking Hemlibra (emicizumab) for hemophilia A were recently published in the International Journal of Hematology (Int J Hematol).Hemlibra is a breakthrough drug mimicking f
Dongwha Pharm said it acquired four over-the-counter (OTC) products from Celltrion, which the latter purchased from Takeda Pharmaceuticals in 2020, for about 37.2 billion won ($27.8 million).The transaction includes medications such as the comprehensive cold medicine Whituben and Whituben Nasal Spra
CanariaBio said the Data and Safety Monitoring Board (DSMB) recommended halting its global phase 3 clinical trial of oregovomab, an antibody targeting CA125, for ovarian cancer patients.The company said that the recommendation was made due to the trial not achieving the necessary statistical value (
Celltrion said Thursday that its anti-cancer drugs are continuing to make an impact by winning tenders in key European countries.First, Celltrion won multiple public hospital consortium bids in France, one of the five largest European countries, EU5: France, Germany, Italy, Spain, and the U.K.Specif
Daewoong Pharmaceutical said Thursday that it had signed a joint sales agreement with LG Chem for the latter's diabetes combination drug, Zemidapa Tab, and started selling it in January.This accord allowed Daewoong to co-market LG Chem's entire diabetes drug lineup, including Zemiglo, Zemimet, and Z
EuBiologics said it will prematurely terminate the phase 3 clinical trials of EuCorVac-19, its Covid-19 vaccine.In January 2022, EuBiologics had received approval from the Ministry of Food and Drug Safety for the phase 3 trial plan of the vaccine.However, the company decided to end the trial due to
Prestige Biologics said it has signed a contract manufacturing organization (CMO) agreement with Celltrion for the latter's clinical materials, amounting to 9 billion won ($6.6 million).This contract represents a 522 percent increase over the previous year's revenue of 1.7 billion won, quintupling t
